Why is this ASX 200 stock crashing 30% today?

What's going with this stock? Let's find out why its shares are deep in the red.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Healius Ltd (ASX: HLS) shares are ending the week deep in the red.

In morning trade, the ASX 200 stock is down 30% to a 52-week low of $1.07.

As a comparison, the benchmark ASX 200 index is up 0.15% at the time of writing.

A man holds his head in his hands, despairing at the bad result he's reading on his computer.

Image source: Getty Images

Why is this ASX 200 stock crashing 30%?

The good news for shareholders is that today's massive decline in the Healius share price is not because of a bad update nor a broker downgrade.

In fact, today's big decline could arguably be good news for them.

That's because the decline has been driven by the healthcare company's shares going ex-dividend this morning for a very special dividend.

When a share goes ex-dividend, it means that the rights to an upcoming dividend payment are now settled. As a result, anyone buying this ASX 200 stock today will not be entitled to receive the Healius dividend when it is paid to shareholders. Instead, it will stay with the seller of the shares even though they no longer own them.

In light of this, a share price will usually drop to reflect this. After all, you don't want to pay for something that you won't receive.

The Healius dividend

Earlier this week, Healius announced plans to pay a special dividend following the completion of the sale of Lumus Imaging to funds managed by Affinity Equity Partners.

The ASX 200 stock received cash proceeds of $822 million, which represented an $965 million enterprise value when adjusted for the repayment of equipment leases and closing adjustments.

Net proceeds are expected to be in excess of $800 million after all transaction fees, separation costs and other fees.

Unfortunately, not all of these funds will be returned to shareholders, but a good portion will be.

The ASX 200 stock is returning $300 million to shareholders through a fully franked special dividend of 41.3 cents per share. Those franking credits equate to 17.7 cents per share or approximately $128 million.

Based on where the Healius share price finished yesterday's session, this equates to a stunning 26.8% fully franked dividend yield.

To put that into context, a $5,000 investment in its shares yesterday would generate approximately $1,340 in dividends.

When is pay day?

The ASX 200 stock's eligible shareholders won't have to wait long for pay day.

The healthcare company is planning to pay this monster dividend to shareholders in two weeks on 23 May.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Healthcare Shares

Why CSL shares are rebounding today after falling to an 8-year low

CSL shares rebound after hitting an 8-year low as brokers see a potential upside.

Read more »

A doctor looks unsure.
Opinions

3 reasons why the CSL share price could leap 87% to $274!

Here's what to expect from the Biotech stock next.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Healthcare Shares

Beaten down: Are Cochlear, Pro Medicus or CSL shares a better buy right now?

Which struggling healthcare stock could bounce back?

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

How high does UBS think CSL shares will go?

This global company is way oversold analysts say.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Macquarie thinks this biotech company's shares could jump more than 50%

Strong royalty flows underpin a bullish valuation.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Growth Shares

3 ASX 200 shares tipped to climb 130% (or more) in the next 12 months

Analysts are bullish about the outlook for these shares.

Read more »

A man sitting at his desktop computer leans forward onto his elbows and yawns while he rubs his eyes as though he is very tired.
Healthcare Shares

Why is this ASX 200 stock sinking 6% today?

This stock is having a tough session. Let's find out what's going on.

Read more »

Portrait, confidence and team of doctors in the hospital standing after a consultation or surgery. Success, healthcare and group of professional medical workers in collaboration at a medicare clinic.
Healthcare Shares

The cutting edge ASX healthcare stock that could rise 50%

Why is the broker bullish on this stock?

Read more »